MADISON O'BRIEN: Open Payments
NPI 1851973267 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 34 payments from 11 companies in 2025. Trend: 2023 $1,642 · 2024 $746 · 2025 $700
Food & beverage: $616Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $184 |
| Madrigal Pharmaceuticals | 8 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
| GENZYME CORPORATION | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Lilly USA, LLC | 2 | $40 |
| ABBVIE INC. | 2 | $32 |
| Ardelyx, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $17 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, ENTYVIO, XIFAXAN, OMVOH, RINVOQ, IBSRELA.
Industry payments across GA — which companies pay providers there.
